UNLOCKING THE POTENTIAL OF COENZYME Q10: FROM CELLULAR ENERGY TO CLINICAL APPLICATIONS

Coenzyme Q10 (CoQ10) is a lipid-soluble molecule with a benzoquinone core and a polyisoprenoid side chain, playing a vital role in mitochondrial electron transport and cellular antioxidant defense. Although often regarded as a vitamin-like compound, CoQ10 is endogenously synthesized through a multi-step process involving the mevalonate pathway. It is primarily found in metabolically active tissues such as the heart, liver, kidney, and skeletal muscle. CoQ10 exists in two interconvertible forms—ubiquinone and ubiquinol—essential for maintaining cellular redox balance. Apart from its role in oxidative phosphorylation, CoQ10 contributes to inflammation regulation, lipid metabolism, lysosomal function, and gene expression modulation. Age-related decline and certain medications, particularly statins, reduce CoQ10 levels, potentially leading to mitochondrial dysfunction and associated disorders, including neurodegenerative diseases, cardiovascular conditions, and muscle-related pathologies. Supplementation with CoQ10, particularly in the form of Ubidecarenone, has been explored for its therapeutic potential in mitigating oxidative stress and improving mitochondrial function. Clinical studies suggest that CoQ10 supplementation may alleviate statin-induced myopathy and offer protective effects in neurodegenerative and retinal diseases, though bioavailability challenges limit its efficacy. Despite promising preclinical findings, the precise therapeutic dosage and long-term clinical benefits remain under investigation. While synthetic derivatives like Idebenone show potential in neurodegenerative treatment, further research is required to establish optimal formulations and administration strategies. Standardizing dosing regimens and improving bioavailability are crucial to maximizing CoQ10’s clinical utility. This review highlights the diverse physiological roles of CoQ10 and its potential implications in aging, disease prevention, and therapeutic intervention.

Authors

Institutions

Publication Details

Journal
Journal of Applied Pharmaceutical Sciences and Research
Published
2025-05-18
DOI
https://doi.org/10.31069/japsr.v8i1.01
Primary Topic
Coenzyme Q10 studies and effects
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

UNLOCKING THE POTENTIAL OF COENZYME Q10: FROM CELLULAR ENERGY TO CLINICAL APPLICATIONS

Aditya Singh, Shahid Naeem, Farida Ahmad
Journal of Applied Pharmaceutical Sciences and Research
Coenzyme Q10 studies and effects
article

UNLOCKING THE POTENTIAL OF COENZYME Q10: FROM CELLULAR ENERGY TO CLINICAL APPLICATIONS

Aditya Singh, Shahid Naeem, Farida Ahmad
article en

Abstract

Coenzyme Q10 (CoQ10) is a lipid-soluble molecule with a benzoquinone core and a polyisoprenoid side chain, playing a vital role in mitochondrial electron transport and cellular antioxidant defense. Although often regarded as a vitamin-like compound, CoQ10 is endogenously synthesized through a multi-step process involving the mevalonate pathway. It is primarily found in metabolically active tissues such as the heart, liver, kidney, and skeletal muscle. CoQ10 exists in two interconvertible forms—ubiquinone and ubiquinol—essential for maintaining cellular redox balance. Apart from its role in oxidative phosphorylation, CoQ10 contributes to inflammation regulation, lipid metabolism, lysosomal function, and gene expression modulation. Age-related decline and certain medications, particularly statins, reduce CoQ10 levels, potentially leading to mitochondrial dysfunction and associated disorders, including neurodegenerative diseases, cardiovascular conditions, and muscle-related pathologies. Supplementation with CoQ10, particularly in the form of Ubidecarenone, has been explored for its therapeutic potential in mitigating oxidative stress and improving mitochondrial function. Clinical studies suggest that CoQ10 supplementation may alleviate statin-induced myopathy and offer protective effects in neurodegenerative and retinal diseases, though bioavailability challenges limit its efficacy. Despite promising preclinical findings, the precise therapeutic dosage and long-term clinical benefits remain under investigation. While synthetic derivatives like Idebenone show potential in neurodegenerative treatment, further research is required to establish optimal formulations and administration strategies. Standardizing dosing regimens and improving bioavailability are crucial to maximizing CoQ10’s clinical utility. This review highlights the diverse physiological roles of CoQ10 and its potential implications in aging, disease prevention, and therapeutic intervention.

Journal of Applied Pharmaceutical Sciences and ResearchVol. 8(01)
Jawaharlal Nehru Medical College Hospital (IN)
Openalex Percentile: Top 81%
Coenzyme Q10 studies and effects
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.